Cleopatra Hospital SAE operates within the General medical & surgical hospitals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Cleopatra Hospital SAE with three other
health care providers in Middle East:
Medicare Group QPSC
sales of 476.80 million Qatari Rial [US$128.62 million]
of which 100%
AYYAN Investment Co SJSC
of SAUDI ARABIA
(257.44 million Saudi Arabian Riyals [US$68.65 million]
of which 93%
was Medical Services), and
Gulf Medical Projects Co PSC
based in UNITED ARAB EMIRATES
(487.26 million UAE Dirham [US$132.66 million]
of which 100%
was HealthServices & Others).
During the year ended December of 2020, sales at
Cleopatra Hospital SAE were 1.99 billion Egyptian Pounds (US$126.89 million).
increase of 10.6%
versus 2019, when the company's sales were 1.80 billion Egyptian Pounds.
This was the fifth consecutive year of sales increases at Cleopatra Hospital SAE
(and since 2015, sales have increased a total of 386%).
Sales of Chg Pharma for Pharmacies saw an increase
that was more than double the company's growth rate: sales were up
291.2% in 2020, from
3.97 million Egyptian Pounds to 15.55 million Egyptian Pounds.
Cleopatra Hospital SAE also saw significant increases in sales in
Chg for Medical Services (up 99.5% to 42.85 million Egyptian Pounds)
Not all segments of Cleopatra Hospital SAE experienced an increase in sales in 2020:
sales of Cowens Hospital fell 24.2% to 10.33 million Egyptian Pounds.
(However, this segment's sales were only a very small portion of the company's overall sales).
Cleopatra Hospital SAE also experienced decreases in sales in
Cleopatra Hospital (down 0.3% to 748.36 million Egyptian Pounds)
Cairo Spec. Hospital (down 2.5% to 364.53 million Egyptian Pounds)